Ms. Elizabeth Lacaze, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 5708 Hollister Ave, # 236, Goleta, CA 93117 Phone: 805-698-0897 Fax: 805-967-4680 |
Maria-jose Martirene, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 5580 Calle Real, Goleta, CA 93111 Phone: 844-594-0343 |
Miss Diana Zakhour Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 5901 Encina Rd Ste A, Goleta, CA 93117 Phone: 805-681-0035 |
Clair Marie Figueroa Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 256 Big Sur Dr, Goleta, CA 93117 Phone: 805-455-0641 |
Dr. Ruth Watkins Ackerman, PHD, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 5951 Encina Rd, Goleta, CA 93117 Phone: 805-682-3601 |
News Archive
This week, the owners of two secular, for-profit corporations will ask the Supreme Court to take a radical turn and allow them to impose their religious views on their employees -; by refusing to permit them contraceptive coverage as required under the Affordable Care Act. The Supreme Court has consistently resisted claims for religious exemptions from laws that are neutral and apply broadly when the exemptions would significantly harm other people, as this one would. To approve it would flout the First Amendment, which forbids government from favoring one religion over another -; or over nonbelievers (3/22).
A long-sought goal of creating particles that can emit a colorful fluorescent glow in a biological environment, and that could be precisely manipulated into position within living cells, has been achieved by a team of researchers at MIT and several other institutions. The finding is reported this week in the journal Nature Communications.
Among parents, you often hear these four words: "Kids are germ factories." But a new study out of Drexel University's Dornsife School of Public Health found that while you might think bringing more day care facilities to your block might make you and your neighbors sick more often, that doesn't appear to be the case.
Genmab A/S announced today that data from the pivotal trial of zalutumumab in refractory head and neck cancer patients will be presented today at the 2010 American Society of Clinical Oncology Annual Meeting, which will be held June 1-8 in Chicago, Illinois. This is the first controlled study to demonstrate that an EGFr-targeted antibody given as monotherapy induces a clinically meaningful improvement in progression free survival in patients with refractory head and neck cancer who have failed platinum-based chemotherapy.
› Verified 8 days ago